Filing Flows › Volitionrx (VNRX) › Q1 2026 › vs Q1 2025
Volitionrx (VNRX) Q1 2026 vs Q1 2025 (year over year)
Volitionrx's revenue rose $739K (+300%) from $246K in Q1 2025 to $985K in Q1 2026.
Volitionrx, Q1 2026: revenue $985K (+300% year over year), operating margin -543.0%, net loss $6.7M, operating cash flow −$5.3M. The chart draws each line against Q1 2025, the increases inside each band.
Every line
| Line | Q1 2026 | Q1 2025 | Change | % |
|---|---|---|---|---|
| Revenue | $985K | $246K | $739K | +300% |
| Net loss | $6.7M | $5.5M | $1.2M | +22% |
| Costs & expenses | $7.7M | $5.8M | $1.9M | +33% |
| Operating costs | $6.3M | $5.8M | $566K | +10% |
| Interest & other, net | $1.4M | −$45K | $1.4M | — |
| Research & development | $2.9M | $2.6M | $245K | +9% |
| Sales & marketing | $852K | $917K | −$65K | -7% |
| General & admin | $2.6M | $2.2M | $386K | +17% |
| Operating cash sources | $6.7M | $5.5M | $1.2M | +22% |
| Depreciation & amortization | $207K | $252K | −$45K | -18% |
| Share-based compensation | $225K | $451K | −$226K | -50% |
| Working capital & other | $991K | $475K | $516K | +109% |
| Cash used in operations | $5.3M | $4.3M | $982K | +23% |
| Net loss absorbed | $6.7M | $5.5M | $1.2M | +22% |
Questions
How much did Volitionrx's revenue grow year over year in Q1 2026?
Volitionrx's revenue rose $739K (+300%) from $246K in Q1 2025 to $985K in Q1 2026.